White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer

PURPOSE: To investigate whether eosinophils and other white blood cell subtypes could be used as response and prognostic markers to anti-Programmed cell Death-1 or anti-PD-Ligand-1 treatments in non-small cell lung cancer patients. METHODS: We retrospectively analyzed data from the NSCLC patients co...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibille, A., Henket, M., Corhay, J. L., Alfieri, R., Louis, R., Duysinx, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510914/
https://www.ncbi.nlm.nih.gov/pubmed/34518898
http://dx.doi.org/10.1007/s00408-021-00474-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510914/
https://www.ncbi.nlm.nih.gov/pubmed/34518898
http://dx.doi.org/10.1007/s00408-021-00474-2

Ejemplares similares